Interferon alfa-2b (recombinant) | |
---|---|
Trade Name | Intron A |
Orphan Indication | Chronic myeloid leukemia |
USA Market Approval | USA |
USA Designation Date | 1987-06-22 00:00:00 |
Sponsor | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia